Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
136
Publications avec texte intégral
Open Access
53 %
Mots clés
Quantitative microdialysis
Desmin
Thérapie génique
Astrocyte
Myostatin
Cell culture model
Oligodendrocytes
MBNL
Animals
CTG repeats
GABA
AAV
Centronuclear myopathy
Heart failure
Acetylcholinesterase deficiency
Diaphragm
Maximal force
Brain
CTG repeat contractions
Muscle
RNA splicing
Cytoskeleton
Transgenic mouse
Fibrosis
Male
Genotype phenotype correlation
Cell model
Myotonic Dystrophy Type 1
Brain dysfunction
Therapy
Hypoxia
Central nervous system
Dystrophin
Myotonic dystrophy type 1
Autophagy
Glial cells
Cardiac muscle
Skeletal muscle
ACETYLCHOLINESTERASE
Myelin
Antisense oligonucleotide
CRISPR/Cas9
Myotonic Dystrophy
CTG repeat instability
Mice
Muscular dystrophy
Transcriptomics
Myotonic dystrophy mouse models
Transgenic mouse model
Exercice
Mouse model
ARN
CMS
Dynamin 2
CONGENITAL MYATHENIC SYNDROME
Aging
Dystrophie myotonique
Knockout
Glucocorticoids
Expression
PacBio
Oligodendrocyte
DMSXL mice
Dystrophie Myotonique
Humans
CRISPRi
Myotonic dystrophy
In vivo
GSK3
Neuron
Trinucleotide repeat expansion
PCR
KNOCKOUT MICE
Motoneuron
Myotonic Dystrophy type 1
DM1
Mouse models
Antisense oligonucleotides
RNA biology
RNA interference
Astrocytes
Endurance training
Glutamate
BIOLOGIE MOLECULAIRE
Long read sequencing
Alternative splicing
Cell penetrating peptide
Gene Therapy
Acetylcholinesterase knockout mouse
DMPK
Trinucleotide Repeat Expansion
Gene editing
Intermediate filament
Acute coronary syndrome
Duchenne muscular dystrophy
Dilated cardiomyopathy
Exercise
Glucocorticoid-receptor
Heart
Gene therapy